A phase II multicenter randomized controlled trial to compare standard chemoradiation with or without recombinant human endostatin injection (Endostar) therapy for the treatment of locally advanced nasopharyngeal carcinoma: Long-term outcomes update-Reference-Cited by-同舟云学术

A phase II multicenter randomized controlled trial to compare standard chemoradiation with or without recombinant human endostatin injection (Endostar) therapy for the treatment of locally advanced nasopharyngeal carcinoma: Long-term outcomes update

Published:2020-02 Issue:1 Volume:44 Page:100492
ISSN:0147-0272
Container-title:Current Problems in Cancer
language:en
Short-container-title:Current Problems in Cancer

Author:

Li Yuanyuan,Tian Ye,Jin Feng,Wu Weili,Long Jinhua,Ouyang Jinlin,Zhou Yan

Funder

Guizhou Provincial Department of Outstanding Science and Technology Education Talent Special Fund

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference33 articles.

1. Late toxicities after conventional radiation therapy alone for nasopharyngeal carcinoma;Tuan;Radiother Oncol,2012

2. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099;Al-Sarraf;J Clin Oncol,1998

3. The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature;Langendijk;J Clin Oncol,2004

4. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225;Lee;J Clin Oncol,2009

5. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities;Sun;Radiother Oncol,2014

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of concurrent chemoradiotherapy with or without Endostar on the regression of retropharyngeal lymph node and prognosis of patients with locally advanced nasopharyngeal carcinoma: a retrospective study;Journal of Cancer Research and Clinical Oncology;2024-05-04

2. Anti-angiogenesis agents plus chemoradiotherapy for locally advanced nasopharyngeal cancer: a systematic review and meta-analysis;European Archives of Oto-Rhino-Laryngology;2024-04-16

3. Advances of radiotherapy combined with targeted therapy for nasopharyngeal carcinoma;Radiation Medicine and Protection;2023-12

4. CACA guidelines for holistic integrative management of nasopharyngeal carcinoma;Holistic Integrative Oncology;2023-07-24

5. Difference after radiotherapy observed in patients with nasopharyngeal carcinoma;Bulletin du Cancer;2023-05